Arbutus Biopharma Corp
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $35.0M | $204.5M | $109.3M |
| FY2022 | $58.6M | $195.4M | $30.8M |
| FY2023 | $38.4M | $144.4M | $26.3M |
| FY2024 | $34.3M | $131.7M | $36.3M |
| FY2025 | $18.0M | $94.6M | $18.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $35.0M | $204.5M | $109.3M |
| FY2022 | $58.6M | $195.4M | $30.8M |
| FY2023 | $38.4M | $144.4M | $26.3M |
| FY2024 | $34.3M | $131.7M | $36.3M |
| FY2025 | $18.0M | $94.6M | $18.0M |